A recent article in BMJ Global Health addresses growing concerns over the high prices of vaccines, particularly for mpox, in low- and middle-income countries (LMICs). The authors argue that current pricing models often fail to reflect the actual costs and public health value of vaccines, leading to inequities in access.
The piece calls for greater transparency in vaccine pricing and urges global health stakeholders to consider alternative valuation methods that prioritize affordability and equitable access. By reassessing how vaccine prices are determined, the article suggests that more sustainable and fair pricing strategies can be developed, benefiting both suppliers and recipients in LMICs.
Thumbnail image credit: Shutterstock / Creative Design nacional
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.